SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (1107)11/20/1998 11:13:00 PM
From: Anthony Wong  Respond to of 1722
 
GM, Citigroup Among Marsico's Recommendations on 'Rukeyser'

Bloomberg News
November 20, 1998, 10:31 p.m. ET

Owings Mills, Maryland, Nov. 20 (Bloomberg) -- General
Motors Corp. and Citigroup were among the companies recommended
by Thomas F. Marsico, Chairman and Chief Executive Officer of
Marsico Capital Management LLC, on Public Broadcasting System's
''Wall Street Week With Louis Rukeyser'' program.

Marsico, whose funds invest in companies with large stock-
market capitalizations, said GM could earn $9 a share next year,
compared with $8.70 a share in 1997 and a projected $4.52 in
1998, the average estimate of analysts surveyed by First Call
Corp. He expects Citigroup, which was formed in October by the
merger of Citicorp and Travelers Group Inc., to earn as much as
$6 a share over the next 18 months.

GM, which is recovering from a 54-day strike this summer
that crippled North American output and cost it $2 billion,
should grow as it goes ''through a total restructuring of (its)
operations'' and introduces new products, Marsico said. It is
benefiting from a lower U.S. dollar against the Japanese yen and
lower commodity prices, Marsico said.

Meanwhile, Marsico thinks Citigroup can have an 18 percent
to 20 percent return on equity.

Marsico also recommended some companies that are helping to
build the infrastructure of the Internet. These include
International Business Machines Corp., Cisco Systems Inc. and
Lucent Technologies Inc.

Among the panelists, Prudential Securities Inc. technical
analyst Ralph Acampora recommended Johnson & Johnson and Eli
Lilly & Co.
, which this week agreed to sell its PCS Health
Systems unit to Rite Aid Corp. for $1.6 billion. He also likes
Texas Instruments Inc. and Philip Morris Cos.

''A lot of money is falling into the big names,'' Acampora
said.

Barbara Marcin, senior portfolio manager at Citibank Global
Asset Management, recommended American Home Products Corp., which
she said has ''really lagged the other'' drug companies since its
planned merger with Monsanto Co. fell through in October, and
Martin Marietta Materials Inc.

Brian Rogers, a managing director at T. Rowe Price, sees
''opportunity'' in Starwood Lodging, Unocal Corp. and BankAmerica
Corp.

--Courtney Schlisserman in the New York newsroom (212) 318-2300